Medtronic has a green light from regulators to begin studies that could lead to automated insulin delivery. A feature in the company's insulin pumps stops sending insulin when blood sugar levels get too low.
Wild win battle of NHL's hottest teams, extend winning streak to six
Kirill Kaprizov delivered a shootout winner to take down the Maple Leafs.
Popular Minneapolis taproom to start requiring proof of vaccination
The new policy will only apply to indoor service.
Vikings downgrade Eric Kendricks to out against Lions
The Vikings have also activated Michael Pierce from injured reserve.
Minnesotan sentenced after assaulting man with baseball bat
Marshall Wayne Boshey was sentenced to 30 months in prison followed by two years of supervised release.
Target's gift card discount is back, but for this weekend only
The fine print: for Target Circle members only (but membership is free).
Minneapolis teen arrested in St. Cloud after fleeing police in stolen vehicle
The vehicle was stolen in a car-jacking in Minneapolis Thursday.
Watch: St. Cloud State's Jami Krannila uses 'The Michigan' to score against North Dakota
Gopher fans avert your eyes.
Prosecutor seeks new charge against Duluth officer who shot through man's door
Tyler Leibfried's trial is set to begin early next year.
Winter storm warnings issued with heavy snow set to slam MN
Parts of northern Minnesota could see more than a foot of snow, but there won't be much in the Twin Cities.
St. Cloud suspect now charged in two local murder cases
Both murders happened within a day of each other in June.
Minnesota-based Medtronic to get $17M for artificial pancreas research
Fridley-based Medtronic will be getting $17 million over the next three years for an initiative aimed at stabilizing blood sugar levels in diabetics. The medical technology company announced Friday that they are getting the money from the Juvenile Diabetes Research Foundation and the Helmsley Charitable Trust to improve existing and develop new artificial pancreas technology.
Panel tells FDA risks of Medtronic heart device outweigh benefits
The news is a blow for Medtronic and investors, who expected big things from an experimental device that uses extreme heat to regulate heartbeat. Medtronic bought the company that developed the device for $225 million in 2009. The panel's recommendation isn't the final say, but the FDA will take it under consideration.
Medtronic seeks partner in brain pump project
Fridley-based Medtronic is looking for pharmaceutical industry partners as it seeks to advance a pump technology, which Medtronic believes could be a good delivery system for Alzheimer's medicines pushed directly into the brain, the Pioneer Press reports.
Clinics testing Medtronic device for stubbornly high blood pressure
The Mayo Clinic is among medical centers testing a device for patients whose high blood pressure does not respond to drugs. Medtronic's device uses a groundbreaking treatment to disrupt nerve signals that elevate blood pressure. But to qualify for the trial, patients must meet strict requirements that are challenging clinics and frustrating rejected patients.
You Can Get BMTN Special Offers!